312 related articles for article (PubMed ID: 31611872)
21. Evaluating the Role of Microglial Cells in Clearance of Aβ from Alzheimer's Brain.
Manchikalapudi AL; Chilakala RR; Kalia K; Sunkaria A
ACS Chem Neurosci; 2019 Mar; 10(3):1149-1156. PubMed ID: 30609357
[TBL] [Abstract][Full Text] [Related]
22. LRP1 modulates the microglial immune response via regulation of JNK and NF-κB signaling pathways.
Yang L; Liu CC; Zheng H; Kanekiyo T; Atagi Y; Jia L; Wang D; N'songo A; Can D; Xu H; Chen XF; Bu G
J Neuroinflammation; 2016 Dec; 13(1):304. PubMed ID: 27931217
[TBL] [Abstract][Full Text] [Related]
23. TREM2, Microglia, and Neurodegenerative Diseases.
Yeh FL; Hansen DV; Sheng M
Trends Mol Med; 2017 Jun; 23(6):512-533. PubMed ID: 28442216
[TBL] [Abstract][Full Text] [Related]
24. 4Aβ1-15-Derived Monoclonal Antibody Reduces More Aβ Burdens and Neuroinflammation than Homologous Vaccine in APP/PS1 Mice.
Zhang Y; Zou J; Yang J; Yao Z
Curr Alzheimer Res; 2015; 12(4):384-97. PubMed ID: 25817256
[TBL] [Abstract][Full Text] [Related]
25. Innate immunity in Alzheimer's disease.
Heneka MT; Golenbock DT; Latz E
Nat Immunol; 2015 Mar; 16(3):229-36. PubMed ID: 25689443
[TBL] [Abstract][Full Text] [Related]
26. Microglia, neuroinflammation, and beta-amyloid protein in Alzheimer's disease.
Cai Z; Hussain MD; Yan LJ
Int J Neurosci; 2014 May; 124(5):307-21. PubMed ID: 23930978
[TBL] [Abstract][Full Text] [Related]
27. Microglia in Alzheimer's disease: A multifaceted relationship.
ElAli A; Rivest S
Brain Behav Immun; 2016 Jul; 55():138-150. PubMed ID: 26254232
[TBL] [Abstract][Full Text] [Related]
28. The neuroinflammatory response in plaques and amyloid angiopathy in Alzheimer's disease: therapeutic implications.
Rozemuller AJ; van Gool WA; Eikelenboom P
Curr Drug Targets CNS Neurol Disord; 2005 Jun; 4(3):223-33. PubMed ID: 15975026
[TBL] [Abstract][Full Text] [Related]
29. Inflammasome-mediated innate immunity in Alzheimer's disease.
Venegas C; Heneka MT
FASEB J; 2019 Dec; 33(12):13075-13084. PubMed ID: 31702392
[TBL] [Abstract][Full Text] [Related]
30. Identification and therapeutic modulation of a pro-inflammatory subset of disease-associated-microglia in Alzheimer's disease.
Rangaraju S; Dammer EB; Raza SA; Rathakrishnan P; Xiao H; Gao T; Duong DM; Pennington MW; Lah JJ; Seyfried NT; Levey AI
Mol Neurodegener; 2018 May; 13(1):24. PubMed ID: 29784049
[TBL] [Abstract][Full Text] [Related]
31. Soluble CCL5 derived from bone marrow-derived mesenchymal stem cells and activated by amyloid β ameliorates Alzheimer's disease in mice by recruiting bone marrow-induced microglia immune responses.
Lee JK; Schuchman EH; Jin HK; Bae JS
Stem Cells; 2012 Jul; 30(7):1544-55. PubMed ID: 22570192
[TBL] [Abstract][Full Text] [Related]
32. Influence of microglia and astrocyte activation in the neuroinflammatory pathogenesis of Alzheimer's disease: Rational insights for the therapeutic approaches.
Ahmad MH; Fatima M; Mondal AC
J Clin Neurosci; 2019 Jan; 59():6-11. PubMed ID: 30385170
[TBL] [Abstract][Full Text] [Related]
33. Anti-interleukin-17A and anti-interleukin-23 antibodies may be effective against Alzheimer's disease: Role of neutrophils in the pathogenesis.
Katayama H
Brain Behav; 2020 Jan; 10(1):e01504. PubMed ID: 31849180
[TBL] [Abstract][Full Text] [Related]
34. The Potential Role of Chemokines in Alzheimer's Disease Pathogenesis.
Azizi G; Khannazer N; Mirshafiey A
Am J Alzheimers Dis Other Demen; 2014 Aug; 29(5):415-25. PubMed ID: 24408754
[TBL] [Abstract][Full Text] [Related]
35. Early miR-155 upregulation contributes to neuroinflammation in Alzheimer's disease triple transgenic mouse model.
Guedes JR; Custódia CM; Silva RJ; de Almeida LP; Pedroso de Lima MC; Cardoso AL
Hum Mol Genet; 2014 Dec; 23(23):6286-301. PubMed ID: 24990149
[TBL] [Abstract][Full Text] [Related]
36. The contribution of neuroinflammation to amyloid toxicity in Alzheimer's disease.
Minter MR; Taylor JM; Crack PJ
J Neurochem; 2016 Feb; 136(3):457-74. PubMed ID: 26509334
[TBL] [Abstract][Full Text] [Related]
37. CD36 mediates the innate host response to beta-amyloid.
El Khoury JB; Moore KJ; Means TK; Leung J; Terada K; Toft M; Freeman MW; Luster AD
J Exp Med; 2003 Jun; 197(12):1657-66. PubMed ID: 12796468
[TBL] [Abstract][Full Text] [Related]
38. Alzheimer's disease: Innate immunity gone awry?
VanItallie TB
Metabolism; 2017 Apr; 69S():S41-S49. PubMed ID: 28129888
[TBL] [Abstract][Full Text] [Related]
39. The LPS receptor (CD14) links innate immunity with Alzheimer's disease.
Fassbender K; Walter S; Kühl S; Landmann R; Ishii K; Bertsch T; Stalder AK; Muehlhauser F; Liu Y; Ulmer AJ; Rivest S; Lentschat A; Gulbins E; Jucker M; Staufenbiel M; Brechtel K; Walter J; Multhaup G; Penke B; Adachi Y; Hartmann T; Beyreuther K
FASEB J; 2004 Jan; 18(1):203-5. PubMed ID: 14597556
[TBL] [Abstract][Full Text] [Related]
40. Role of the immune system in the pathogenesis, prevention and treatment of Alzheimer's disease.
Blasko I; Grubeck-Loebenstein B
Drugs Aging; 2003; 20(2):101-13. PubMed ID: 12534311
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
